Horan Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Horan Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,334	Closed	-$213K	–	114
2023 Q2	$213K	Hold	3,334	–	–	0.08%	102
2023 Q1	$231K	Buy	+3,334	New	+$235K	0.1%	96
2022 Q3	–	Sell	-2,780	Closed	-$214K	–	88
2022 Q2	$214K	Hold	2,780	–	–	0.1%	87
2022 Q1	$203K	Buy	+2,780	New	+$187K	0.08%	95
2020 Q4	–	Sell	-2,680	Closed	-$162K	–	110
2020 Q3	$162K	Buy	+2,680	New	+$161K	0.09%	92
2020 Q1	–	Sell	-2,959	Closed	-$190K	–	98
2019 Q4	$190K	Sell	2,959 -53	-2%	-$3.04K	0.11%	75
2019 Q3	$153K	Buy	+3,012	New	+$142K	0.09%	79
2019 Q2	–	Sell	-3,012	Closed	-$144K	–	95
2019 Q1	$144K	Buy	+3,012	New	+$150K	0.09%	80
2017 Q4	–	Sell	-1,921	Closed	-$122K	–	95
2017 Q3	$122K	Buy	+1,921	New	+$112K	0.08%	94
2014 Q3	–	Sell	-7,211	Closed	-$350K	–	60
2014 Q2	$350K	Buy	7,211 +150	+2%	+$7.39K	0.32%	56
2014 Q1	$367K	Hold	7,061	–	–	0.35%	56
2013 Q4	$375K	Buy	7,061 +701	+11%	+$35.7K	0.38%	56
2013 Q3	$294K	Buy	+6,360	New	+$279K	0.35%	56

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Horan Capital Advisors's BMY Position: Q3 2023 in Review

Horan Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,334 shares — an estimated $213K sold.

Horan Capital Advisors first reported a position in BMY in Q3 2013 and held it in 13 quarters. The position peaked at $375K in Q4 2013. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Horan Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Horan Capital Advisors sold 3,334 Bristol-Myers Squibb shares in Q3 2023, an estimated $213K.
Horan Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 13 quarters.
Horan Capital Advisors's Bristol-Myers Squibb position peaked at $375K in Q4 2013.
2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Horan Capital Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.